XML 71 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
9 Months Ended
Sep. 30, 2014
SEGMENT INFORMATION  
SEGMENT INFORMATION

NOTE 13 – SEGMENT INFORMATION

 

The Company operates in the packaging components industry, which includes the development, manufacture and sale of consumer product dispensing solutions.  The Company is organized into three reporting segments.  Operations that sell dispensing systems primarily to the personal care, beauty and home care markets form the Beauty + Home segment.  Operations that sell dispensing systems primarily to the prescription drug, consumer health care and injectables markets form the Pharma segment.  Operations that sell dispensing systems primarily to the food and beverage markets form the Food + Beverage segment.

The accounting policies of the segments are the same as those described in Note 1, Summary of Significant Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.  Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and related depreciation and income taxes.

 

Financial information regarding the Company’s reportable segments is shown below:

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

 

Total Revenue:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

384,604

 

$

379,250

 

$

1,174,359

 

$

1,125,261

 

Pharma

 

179,191

 

172,360

 

569,230

 

524,248

 

Food + Beverage

 

94,118

 

75,531

 

274,936

 

244,434

 

Total Revenue

 

657,913

 

627,141

 

2,018,525

 

1,893,943

 

 

 

 

 

 

 

 

 

 

 

Less: Intersegment Sales:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

5,699

 

$

3,199

 

$

18,992

 

$

10,754

 

Pharma

 

--

 

90

 

--

 

178

 

Food + Beverage

 

272

 

208

 

909

 

293

 

Total Intersegment Sales

 

$

5,971

 

$

3,497

 

$

19,901

 

$

11,225

 

 

 

 

 

 

 

 

 

 

 

Net Sales:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

378,905

 

$

376,051

 

$

1,155,367

 

$

1,114,507

 

Pharma

 

179,191

 

172,270

 

569,230

 

524,070

 

Food + Beverage

 

93,846

 

75,323

 

274,027

 

244,141

 

Net Sales

 

$

651,942

 

$

623,644

 

$

1,998,624

 

$

1,882,718

 

 

 

 

 

 

 

 

 

 

 

Segment Income:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

25,399

 

$

30,943

 

$

80,378

 

$

85,697

 

Pharma

 

49,314

 

44,737

 

154,589

 

141,154

 

Food + Beverage

 

11,713

 

7,688

 

33,209

 

28,102

 

Restructuring Initiatives and

 

 

 

 

 

 

 

 

 

Related Depreciation (1)

 

--

 

(2,664

)

--

 

(10,257

)

Corporate & Other

 

(8,364

)

(8,113

)

(28,664

)

(27,605

)

Income before interest and taxes

 

$

78,062

 

$

72,591

 

$

239,512

 

$

217,091

 

Interest expense, net

 

(3,946

)

(4,265

)

(12,010

)

(13,093

)

Income before income taxes

 

$

74,116

 

$

68,326

 

$

227,502

 

$

203,998

 

 

(1)

Restructuring Initiatives and Related Depreciation includes the following income/(expense) items for the three and nine months ended September 30, 2014:

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

 

European Restructuring Plan

 

 

 

 

 

 

 

 

 

Depreciation

 

$

--

 

$

484

 

$

--

 

$

1,499

 

Employee Severance and Other Costs

 

--

 

2,180

 

--

 

8,802

 

Prior Year Initiatives

 

--

 

--

 

--

 

(44

)

Total Restructuring Initiatives and Related Depreciation Expense

 

$

--

 

$

2,664

 

$

--

 

$

10,257

 

 

 

 

 

 

 

 

 

 

 

Restructuring Initiatives and Related Depreciation Expense by Segment

 

 

 

 

 

Beauty + Home

 

$

--

 

$

2,664

 

$

--

 

$

10,280

 

Pharma

 

--

 

--

 

--

 

--

 

Food + Beverage

 

--

 

--

 

--

 

(23

)

Total Restructuring Initiatives and Related Depreciation Expense

 

$

--

 

$

2,664

 

$

--

 

$

10,257